The Fraunhofer Institute for Biomedical Engineering IBMT acts as a device and technology developer when it comes to the solution of individual research and development projects and tasks from the areas of biomedical/medical engineering, medical (molecular and cellular) biotechnology, biohybrid technology, bioprocessing & bioanalytics, cryo(bio)technology and nano(bio)technology, ultrasound technology, biomedical microsystems, neuroprosthetics and implants, health information systems, theranostics, (mobile) laboratory technology as well as laboratory automation including in-line/on-line process control. For more than 10 years, Fraunhofer IBMT has been working in the field of stem cell research and hosting extensive cell line stocks in industrial and clinically structured biobanks for low temperature storage of valuable samples (fluids, cells, tissue fragments).